JP2016535075A5 - - Google Patents

Download PDF

Info

Publication number
JP2016535075A5
JP2016535075A5 JP2016545270A JP2016545270A JP2016535075A5 JP 2016535075 A5 JP2016535075 A5 JP 2016535075A5 JP 2016545270 A JP2016545270 A JP 2016545270A JP 2016545270 A JP2016545270 A JP 2016545270A JP 2016535075 A5 JP2016535075 A5 JP 2016535075A5
Authority
JP
Japan
Prior art keywords
och
compound
nhch
chcl
chf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016545270A
Other languages
English (en)
Japanese (ja)
Other versions
JP6545177B2 (ja
JP2016535075A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/058137 external-priority patent/WO2015048692A1/en
Publication of JP2016535075A publication Critical patent/JP2016535075A/ja
Publication of JP2016535075A5 publication Critical patent/JP2016535075A5/ja
Application granted granted Critical
Publication of JP6545177B2 publication Critical patent/JP6545177B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016545270A 2013-09-29 2014-09-29 抗菌薬としてのアリール置換アミノメチルスペクチノマイシン類似体 Expired - Fee Related JP6545177B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361884085P 2013-09-29 2013-09-29
US61/884,085 2013-09-29
PCT/US2014/058137 WO2015048692A1 (en) 2013-09-29 2014-09-29 Aryl substituted aminomethyl spectinomycin analogs as antibacterial agents

Publications (3)

Publication Number Publication Date
JP2016535075A JP2016535075A (ja) 2016-11-10
JP2016535075A5 true JP2016535075A5 (enExample) 2017-11-09
JP6545177B2 JP6545177B2 (ja) 2019-07-17

Family

ID=52744583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016545270A Expired - Fee Related JP6545177B2 (ja) 2013-09-29 2014-09-29 抗菌薬としてのアリール置換アミノメチルスペクチノマイシン類似体

Country Status (6)

Country Link
US (1) US10266544B2 (enExample)
EP (1) EP3049154B1 (enExample)
JP (1) JP6545177B2 (enExample)
AU (1) AU2014324535B2 (enExample)
CA (1) CA2924733C (enExample)
WO (1) WO2015048692A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180141897A1 (en) 2014-12-08 2018-05-24 The Research Foundation For The State University Of New York Anti-fungals targeting the synthesis of fungal shingolipids
EP3638649A4 (en) 2017-06-16 2021-03-17 The Research Foundation for The State University of New York FUNGUSKID AGENTS AGAINST THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
US20210388012A1 (en) * 2018-11-05 2021-12-16 St. Jude Children's Research Hospital, Inc. Methods and compositions for prodrug forms of spectinomycin and spectinamide analogs
CN111239265B (zh) * 2018-11-28 2022-07-26 江苏先声药业有限公司 一种测定阿莫西林克拉维酸钾药物组合物中克拉维酸有关物质的液相色谱方法
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3207764A (en) * 1962-01-22 1965-09-21 Upjohn Co Actinospectacin acylates
DE2756914A1 (de) 1977-12-21 1979-07-05 Thomae Gmbh Dr K 4-spectinomycylamin und seine physiologisch vertraegliche salze, verfahren zur herstellung und diese stoffe enthaltende arzneimittel
US4465848A (en) 1981-10-23 1984-08-14 The Upjohn Company Spectinomycin compounds
EP0079125B1 (en) * 1981-10-23 1989-04-05 The Upjohn Company 3-substituted spectinomycin analogues and their preparation
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
EP1278542A2 (en) 2000-05-05 2003-01-29 Cytos Biotechnology AG Molecular antigen arrays and vaccines
GB0025414D0 (en) 2000-10-16 2000-11-29 Consejo Superior Investigacion Nanoparticles
CN101675993A (zh) 2003-03-26 2010-03-24 赛托斯生物技术公司 Melan-a肽类似物-病毒样颗粒偶联物
WO2005101466A2 (en) 2003-12-19 2005-10-27 The University Of North Carolina At Chapel Hill Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography
WO2006080951A2 (en) 2004-07-01 2006-08-03 Yale University Targeted and high density drug loaded polymeric materials
US20090226525A1 (en) 2007-04-09 2009-09-10 Chimeros Inc. Self-assembling nanoparticle drug delivery system
MX2010003642A (es) 2007-10-12 2010-08-09 Massachusetts Inst Technology Nanotecnologia de vacuna.
WO2009106999A2 (en) 2008-02-28 2009-09-03 Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts Hollow nanoparticles and uses thereof
WO2010047839A1 (en) 2008-10-25 2010-04-29 Aura Biosciences Modified plant virus particles and uses therefor
CA2768582C (en) * 2009-07-24 2017-02-14 University Of Tennessee Research Foundation Spectinamides as anti-tuberculosis agents
CN101671336B (zh) 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途

Similar Documents

Publication Publication Date Title
ME02490B (me) Hemijska jedinjenja
ME03757B (me) Prolekovi jaki inhibitornih jedinjenja za lečenje gastorintestinalne inflamatorne bolesti
HRP20200648T1 (hr) Derivati sulfamoilpirolamida i njihova uporaba kao lijekova za liječenje hepatitisa b
JP2018534348A5 (enExample)
ME02892B (me) Hemijska jedinjenja
JP2012507566A5 (enExample)
JP2016006118A5 (enExample)
JP2014508811A5 (enExample)
HRP20150096T1 (hr) 2-aminobenzimidazol-5-karboksamidi kao protuupalni agensi
JP2013531029A5 (enExample)
JP2013529196A5 (enExample)
JP2010524932A5 (enExample)
ME02754B (me) Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
SI2945620T1 (en) Nitroxyl donors with improved therapeutic index
JP2012502010A5 (enExample)
JP2013542218A5 (enExample)
CA2744756A1 (en) Monocarbams and their use as antibacterial agent
JP2012504133A5 (enExample)
JP2017501236A5 (enExample)
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2013542261A5 (enExample)
WO2015021396A3 (en) Tricyclic benzoxaborole compounds and uses thereof
JP2013063968A5 (enExample)
JP2015520770A5 (enExample)
HRP20221381T1 (hr) C-manozidni spojevi korisni za liječenje infekcija urinarnog trakta